医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GE Healthcare Announces $300 Million Commitment to Support Emerging Market Health

2015年09月23日 PM09:00
このエントリーをはてなブックマークに追加


 

NEW YORK

GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop high-value, low-cost technologies and healthcare delivery solutions across multiple care settings. The new organization will invest $300 million as part of a multi-phase effort to develop a more robust affordable healthcare portfolio for customers. The unit will combine GE Healthcare’s operations in India, South Asia, Africa and Southeast Asia.

With the vision to improve access to quality and affordable health around the world, SHS will work with governments, clinicians, private operators and NGOs to deliver value-based solutions aimed at improving outcomes for health systems and patients.

“Much of the world’s population is without adequate healthcare, and innovations that can create better patient outcomes in a sustainable way are urgently needed,” said John Flannery, President and CEO of GE Healthcare. “Many emerging economies are looking for experienced partners to help build skills, capacity and effective healthcare solutions for their patients.”

GE Healthcare has a long track record in developing innovations for emerging markets. For example, its handheld ultrasound device Vscan Access+ and Lullaby+ infant warmer are improving outcomes in remote rural settings in maternal infant care, a major focus area for many emerging markets. The low-cost healthcare equipment sector alone is now estimated to be worth over $8 billion and growing significantly as developing countries continue to invest in effective, long-term healthcare solutions to improve the health of their populations.

“SHS will leverage GE’s Fastworks methodology to accelerate, test and rapidly commercialize relevant, affordable technologies. By taking this ‘start-up’ model approach we can rapidly test new ideas, products and services to maximize effectiveness for customers before we scale up,” said Terri Bresenham, President and CEO of GE Healthcare’s Sustainable Healthcare Solutions unit. “From basic primary care delivery through to more complex, structural healthcare challenges, SHS will aim to combine GE Healthcare’s capabilities and scale with the local know-how and expertise of our partners across Africa, Southeast Asia, India and South Asia. “

About GE Healthcare

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

* SHS will serve Bangladesh, Bhutan, Brunei, Cambodia, India, Indonesia, Laos, Malaysia, Maldives, Myanmar, Nepal, Philippines, Singapore, Sri Lanka, Thailand, Vietnam + all 54 African countries.

+ Vscan Access and the Lullaby infant warmer are not for sale in all countries. Please contact your GE Sales Representative for information about availability in your area.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150923005242/en/

CONTACT

GE Healthcare
Mirielle Ranade, Communications
Mirielle.Ranade@ge.com
+65
9118 2214
or
GE Healthcare
Ben Fox, Communications
Benjamin.Fox@ge.com
+1
414 721 4013

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表